| Nov 11 |
Axsome Therapeutics Q3 2024 Earnings Preview
|
| Nov 8 |
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
|
| Nov 5 |
Analysts Estimate Axsome Therapeutics (AXSM) to Report a Decline in Earnings: What to Look Out for
|
| Oct 29 |
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
|
| Oct 21 |
Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
|
| Oct 19 |
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
|
| Oct 15 |
Axsome: AXS-07 And Its Upcoming Second PDUFA
|
| Oct 15 |
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
|
| Sep 29 |
1 Under-the-Radar Biotech Stock to Buy and Hold
|
| Sep 24 |
Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
|
